Back

Real-world evaluation of performance and practical utility of multi-biomarker risk report for cardiovascular and other chronic diseases

26 April 2024 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: How should we assess cardiovascular risk? Scores, prediction algorithms and analysis methods Cardiovascular Risk Assessment Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Sini Kerminen

Nightingale Health Plc, Helsinki (Finland)

5 More presentations in this session

Presentation thumbnail
Heterogeneous associations of traditional atherosclerotic risk factors and long-term complications in different arterial territories: the EPIC Norfolk prospective population cohort
Ms M. van den Bogaart (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Optimization and validation of high, intermediate and low risk cut-off points in risk functions for primary cardiovascular prevention. The ORESTES project.
Ms N. Herrera Marin (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Is GRACE 2.0 a better predictor of post-MI mortality than GRACE in patients with known diabetes compared to those without?
Doctor B. Soman (Great Yarmouth, GB)
Abstract Slides
Presentation thumbnail
Improved sex-specific cardiovascular disease risk prediction using machine learning and explainable artificial intelligence
Ms V. De Martin T (Trondheim, NO)
Abstract Slides
Presentation thumbnail
Intima-media thickness measured at the common carotid artery, carotid bifurcation, and internal carotid artery in cardiovascular risk assessment
Doctor L. Seekircher (Innsbruck, AT)
Abstract Slides

Access the full session

Session thumbnail
How should we assess cardiovascular risk? Scores, prediction algorithms and analysis methods

The Event

Event poster

ESC Preventive Cardiology 2024

26 April 2024 16:15 CET
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources